Citizens Business Bank Makes New $916,000 Investment in Synopsys, Inc. $SNPS

Citizens Business Bank bought a new stake in Synopsys, Inc. (NASDAQ:SNPS) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,857 shares of the semiconductor company’s stock, valued at approximately $916,000.

Several other large investors also recently modified their holdings of the stock. Alpine Bank Wealth Management lifted its stake in Synopsys by 89.3% in the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 25 shares during the last quarter. TFC Financial Management Inc. increased its position in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after buying an additional 50 shares during the last quarter. Millstone Evans Group LLC bought a new stake in shares of Synopsys in the third quarter valued at $27,000. SOA Wealth Advisors LLC. purchased a new position in shares of Synopsys during the 3rd quarter valued at $28,000. Finally, McIlrath & Eck LLC bought a new position in shares of Synopsys during the 3rd quarter worth $29,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Stock Performance

NASDAQ SNPS opened at $449.17 on Thursday. The company’s 50 day simple moving average is $472.85 and its two-hundred day simple moving average is $479.02. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The stock has a market capitalization of $86.04 billion, a PE ratio of 56.22, a P/E/G ratio of 3.67 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping the consensus estimate of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business’s quarterly revenue was up 65.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 beat and strong results — Synopsys reported non‑GAAP EPS of $3.77 and revenue of $2.409B, topping estimates and showing strong year‑over‑year growth; the quarter came at the high end of prior guidance. PR Newswire: Q1 Results
• Positive Sentiment: Very bullish guidance — management raised FY26 EPS guidance to $14.38–$14.46 and Q2 EPS guidance to $3.11–$3.17, well above Street estimates, which is driving optimism about near‑term earnings power. Guidance/Press Release
• Positive Sentiment: Capital return boost — the board authorized up to $2.0B in additional share repurchases, which supports EPS and signals confidence from management. Buyback Announcement
• Positive Sentiment: Analyst and market interest — Morgan Stanley reiterated a Buy and noted strong earnings quality and IP trajectory; unusual call‑option buying also points to bullish trader positioning. TipRanks: Morgan Stanley Buy
• Neutral Sentiment: Mixed near‑term revenue signal — while EPS guidance was raised, quarterly revenue guidance landed roughly in line with expectations, suggesting upside is currently EPS‑driven rather than revenue surprise. Guidance Details
• Negative Sentiment: China export restrictions and muted next‑quarter outlook — Reuters flagged Synopsys forecasting a more muted quarter amid China export limits and macro uncertainty, which pressured the stock earlier and could cap upside if geopolitical risk persists. Reuters: China Export Restrictions
• Negative Sentiment: Leverage concerns from M&A — commentators note Synopsys carries large incremental debt (post‑deal) that investors are watching closely; higher leverage raises sensitivity to execution and could limit valuation expansion. 24/7 Wall St.: Debt Concerns

Insider Transactions at Synopsys

In other Synopsys news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 4,157 shares of company stock valued at $1,945,036. Corporate insiders own 0.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on SNPS. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and lowered their price objective for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. HSBC downgraded shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a report on Friday, February 20th. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Finally, The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the stock a “buy” rating in a report on Wednesday. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $547.00.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.